Indefinite Delivery Contract SPM2DX14D2018

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award IDC, valued up to $499,999,999, covers a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide under the SPE2DB program.

Through this IDC, DMS Pharmaceutical Group provides both routine and critical medications, including flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications, to support the diverse medical requirements of the Department of Defense (DoD) healthcare system. The firm fixed-price delivery orders issued under this contract do not have any set-aside designations, leveraging DMS Pharmaceutical Group's woman-owned small business status. This IDC complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.